Evidence map›Paper›PMID 8876196›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1996

The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner.

K Xia, N K Mukhopadhyay, R C Inhorn, D L Barber, P E Rose, R S Lee, R P Narsimhan, A D D'Andrea, J D Griffin, T M Roberts

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 82 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. JAK2 is required for induction of the murine DUB-1 gene.Molecular and cellular biology · 1997
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

K XiaDana-Farber Cancer Institute, Boston, MA, USA.
N K Mukhopadhyay
R C Inhorn
D L Barber
P E Rose
R S Lee
R P Narsimhan
A D D'Andrea
J D Griffin
T M Roberts
Harvard University · USDana-Farber Cancer Institute · USHarvard–MIT Division of Health Sciences and Technology · US

Funding

STRUCTURE AND FUNCTION OF THE ERYTHROPOIETIN RECEPTORR01DK043889 · NIDDK · DANA-FARBER CANCER INSTITUTE · PI D'ANDREA, ALAN D. · 1992 to 2014
$5.3M
SURFACE ANTIGENS OF MYELOID PROGENITOR CELLSR01CA036167 · NCI · DANA-FARBER CANCER INSTITUTE · PI GRIFFIN, JAMES DOUGLAS · 1985 to 2007
$1.8M
REGULATION OF MYELOPOIESISR37CA036167 · NCI · DANA-FARBER CANCER INSTITUTE · PI GRIFFIN, JAMES D · 1995 to 2002
$863k
SRC FAMILY OF NONRECEPTOR TYROSINE KINASESR01CA043803 · NCI · DANA-FARBER CANCER INSTITUTE · PI ROBERTS, THOMAS M · 1987 to 2000
$298k
Mechanism of Bone Marrow Failure in Fanconi AnemiaR56DK043889 · NIDDK · DANA-FARBER CANCER INST · PI D'ANDREA, ALAN D. · 2015 to 2015
$127k
NCI NIH HHS CA36167NCI NIH HHS CA43803NIDDK NIH HHS DK43889
6 · The paper itself

Abstract

JAK2, a member of the Janus kinase superfamily was found to interact functionally with Raf-1, a central component of the ras/mitogen-activated protein kinase signal transduction pathway. Interferon-gamma and several other cytokines that are known to activate JAK2 kinase were also found to stimulate Raf-1 kinase activity toward MEK-1 in mammalian cells. In the baculovirus coexpression system, Raf-1 was activated by JAK2 in the presence of p21ras. Under these conditions, a ternary complex of p21ras, JAK2, and Raf-1 was observed. In contrast, in the absence of p21ras, coexpression of JAK2 and Raf-1 resulted in an overall decrease in the Raf-1 kinase activity. In addition, JAK2 phosphorylated Raf-1 at sites different from those phosphorylated by pp60v-src. In mammalian cells treated with either erythropoietin or interferon-gamma, a small fraction of Raf-1 coimmunoprecipitated with JAK2 in lysates of cells in which JAK2 was activated as judged by its state of tyrosine phosphorylation. Taken together, these data suggest that JAK2 and p21ras cooperate to activate Raf-1.

Indexed as

Mitogen-Activated Protein Kinase KinasesAnimalsCalcium-Calmodulin-Dependent Protein KinasesCell LineCytokinesEnzyme ActivationErythropoietinGranulocyte-Macrophage Colony-Stimulating FactorHeLa CellsHumansInterferon-gammaInterleukin-2Janus Kinase 2MAP Kinase Kinase 1Protein Serine-Threonine KinasesProtein-Tyrosine KinasesCalcium-Calmodulin-Dependent Protein KinasesCytokinesErythropoietinGranulocyte-Macrophage Colony-Stimulating FactorHRAS protein, humanInterferon-gammaInterleukin-2JAK2 protein, humanJanus Kinase 2MAP2K1 protein, humanMAP Kinase Kinase 1Mitogen-Activated Protein Kinase KinasesProtein Serine-Threonine KinasesProtein-Tyrosine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-rafProto-Oncogene Proteins p21(ras)Recombinant Proteins

Identifiers

PMID8876196
PMCPMC38118
OpenAlexW2068430386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.